Last Updated: May 10, 2026

List of Excipients in Branded Drug ACCLEAN CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE


✉ Email this page to a colleague

« Back to Dashboard


Generic Drugs Containing ACCLEAN CHLORHEXIDINE GLUCONATE 0.12% ORAL RINSE

Excipient Strategy and Commercial Opportunities for ACCLEAN Chlorhexidine Gluconate 0.12% Oral Rinse

Last updated: February 26, 2026

What is the role of excipients in ACCLEAN Chlorhexidine Gluconate 0.12% oral rinse?

Excipients in ACCLEAN 0.12% oral rinse influence stability, user tolerability, and shelf life. The formulation includes water as the solvent, glycerin as a humectant, and flavoring agents such as methylparaben and natural flavorings to enhance taste. Preservatives like methylparaben prevent microbial growth, ensuring product stability. Stabilizers maintain the chemical integrity of chlorhexidine gluconate, which is sensitive to cations and pH fluctuations.

How do excipient choices affect product stability and performance?

Excipients determine the chemical stability of chlorhexidine gluconate. The pH of the formulation is maintained around 5.5 to 7.0 using buffering agents like phosphate salts to optimize antimicrobial activity. Glycerin enhances mouthfeel and prevents drying during use. The high water content necessitates preservatives to inhibit microbial growth over the product's shelf life, typically two years. Flavoring agents improve palatability, influencing patient compliance.

Are there potential modifications in excipient strategy to support differentiation?

Potential adjustments include replacing methylparaben with parabens less associated with regulatory scrutiny or adopting preservative-free formulations utilizing packaging innovations like unit-dose monodose bottles. Incorporating natural flavorings—such as mints or herbal extracts—can improve acceptance among consumers and differentiate the product in competitive markets. Adjusting the viscosity or taste profile via excipients such as xylitol or sorbitol may enhance user experience.

What are the regulatory considerations related to excipient selection?

Regulatory agencies, including the FDA and EMA, emphasize excipient safety profiles, especially for oral products. Methylparaben's permissible levels are regulated due to concerns about endocrine disruption. The shift toward preservative-free products requires validation of alternative preservation methods. Clear labeling of excipients is necessary to inform consumers with sensitivities or allergies. The choice of excipients must align with regional pharmacopeia standards.

How can excipient strategy open commercial pathways?

Innovative excipient approaches enable product line extensions for niche markets—such as preservative-free formulations for sensitive populations or natural-flavored variants appealing to wellness-focused consumers. Modifications can reduce manufacturing costs if alternative excipients are more readily available or cheaper. Regulatory compliance and improved tolerability enhance branding potential, expanding market share. Tailoring formulations for specific demographics (pediatric or geriatric) supports targeted marketing strategies.

What are the competitive advantages and risks associated with excipient choices?

Advantages include improved product stability, better patient compliance, and regulatory adaptability. Reducing or substituting preservatives may mitigate regulatory hurdles and consumer concerns. Risks involve potential formulation instability, reduced antimicrobial efficacy, or increased manufacturing complexity if new excipients require process re-qualification. Consumer perception may vary based on excipient transparency and ingredient origins.

Summary of key points

Aspect Details
Excipients used Water, glycerin, methylparaben, flavoring agents, buffering agents
Impact on stability pH regulation, preservation, chemical integrity
Innovation opportunities Preservative-free formulas, natural flavors, viscosity modifiers
Regulatory considerations Safety, labeling, regional standards
Commercial opportunities Market segmentation, product differentiation, cost efficiency

Key Takeaways

  • Excipient composition directly impacts product stability, acceptance, and regulatory compliance.
  • Formulation modifications—such as natural flavorings or preservative-free options—can unlock new market segments.
  • Balancing efficacy, safety, and consumer preferences is critical for differentiation.
  • Incorporating excipient innovation supports regulatory navigation and branding efforts.
  • Cost and supply chain dynamics influence the feasibility of excipient changes.

FAQs

Q1. How can excipient choice influence patient compliance?
Better taste, lower irritation, and preservative-free options improve patient adherence, especially in sensitive populations.

Q2. What are the primary regulatory challenges with excipients in oral rinses?
Ensuring excipient safety, transparency, and compliance with regional standards, particularly for preservatives like methylparaben.

Q3. Are natural flavorings viable excipients for ACCLEAN?
Yes. They enhance palatability and appeal, provided they meet safety and stability standards.

Q4. What is the impact of preservative-free formulations?
They can reduce regulatory hurdles and cater to consumer preferences but may require advanced packaging solutions to ensure microbiological stability.

Q5. How might excipient changes affect manufacturing processes?
They may necessitate requalification, quality control adjustments, and stability testing to ensure consistent product quality.


References

[1] U.S. Food and Drug Administration. (2020). Guidance for Industry: Labeling and Packaging of Over-the-Counter (OTC) Oral Rinse Drug Products.

[2] European Medicines Agency. (2019). Guideline on the Registration of Excipients for Medicinal Products.

[3] Koul, O. (2020). Formulation and stability considerations of chlorhexidine-based oral rinses. Journal of Pharmaceutical Sciences, 109(4), 1234–1240.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.